Light in the dark: The search for new treatments for hereditary blindness

One night, Tomás realized something was seriously wrong. He went for a stroll, along the same paths near his village that he ...
Ophthalmology Times

FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa

RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...